IP Cases — 2025
4,177 decisions across all jurisdictions
Page 4 of 140 · 4,177 total
Microsoft Corporation v.Sandpiper CDN, LLC
Microsoft seeks Director Review of a PTAB institution decision that ordered review of an expired content‑delivery patent owned by Sandpiper CDN. The petition argues the Board misapplied settled‑expectations doctrine and misread the district‑court record, making the decision an outlier.
Ebury Partners UK Ltd. v.--
Ebury Partners UK Ltd. moved to withdraw its IPR petition after settling with Intercurrency Software LLC. The Board was asked to terminate the proceeding, which was unopposed and at an early stage.
Microsoft Corporation v.Sandpiper CDN, LLC
The PTAB denied Google’s petitions for Director Review of institution decisions in four IPRs against Sandpiper CDN, keeping the institutions intact.
Microsoft Corporation v.Sandpiper CDN, LLC
Microsoft has filed an IPR petition challenging Sandpiper CDN’s 9,762,692 patent covering CDN popularity‑based routing and content partitioning, asserting obviousness over Seed and Swildens references.
Ebury Partners UK Ltd. v.--
Ebury Partners UK Ltd. petitions the PTAB to invalidate 16 claims of Intercurrency Software’s ‘701 patent, asserting that the claims are obvious over a combination of prior‑art trading systems (Calo, Rude, Sellberg, Szoc, Davidowitz).
R P Scherer Technologies Llc v.The Patent Office of India
The petitioner challenged the rejection of its Indian Patent Application (No. 202127050600) by the Assistant Controller on grounds of lacking inventive step. The core issue was whether the claimed formulation for oral delivery of poorly permeable proteins/peptides was non-obvious over cited prior art. Given the technical nature, the Court appointed a Scientific Advisor to render an opinion.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB instituted an IPR on Inari Medical’s 11,697,012 patent covering hemostasis valves for aspiration catheters after finding a reasonable likelihood that Imperative Care will prevail on at least one of the nine challenged claims.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
Imperative Care challenged Inari Medical’s 11,844,921 B2 hemostasis valve patent. The PTAB found a reasonable likelihood of unpatentability and instituted inter partes review on all 18 challenged claims.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 B2 catheter aspiration patent after Imperative Care showed a reasonable likelihood of success on at least one claim. The review covers all 15 claims and four obviousness grounds involving Garrison, Schaffer, Hartley, and Eller references.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s 11,974,910 patent after finding Imperative Care likely to succeed on at least one claim, focusing on obviousness over Garrison, Laub, and Aklog references.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB has instituted an inter partes review of Inari Medical’s hemostasis valve patent after finding Imperative Care’s petition shows a reasonable likelihood of success on at least one claim.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
Imperative Care successfully instituted an IPR against Inari Medical's 11,969,333 B2 patent covering intravascular clot removal. The Board found a reasonable likelihood of unpatentability based on obviousness over Laub, Garrison, and related references, and instituted review on all 36 challenged claims.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s hemostasis valve patent after Imperative Care showed a reasonable likelihood of success, focusing on the definition of “filament” and its flexibility versus prior art.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
Imperative Care has filed an IPR petition challenging Inari Medical’s U.S. Patent 12,156,669 covering an endovascular clot‑removal system. The petition asserts anticipation and obviousness over multiple prior‑art references, including Garrison, Goff, Brady, Pons, Schaffer, and Hartley. The Board must decide whether to institute the review.
Dasaprakash Restaurant And Ice Cream Parlour Pvt.Ltd. v.The Deputy Registrar of Trademarks
The Madras High Court dismissed an appeal filed by Dasaprakash Restaurant and Ice Cream Parlour Pvt.Ltd., which sought to record its rights as a subsequent proprietor of the 'Dasaprakash' trademark. The court upheld the Trademark Registry's rejection, ruling that the transfer agreement was void ab initio because it was executed while the original proprietor, Balakrishna Rao, was legally incompetent due to insolvency proceedings. Furthermore, the court emphasized that since the mark was a family mark jointly owned by legal heirs, no single proprietor could unilaterally transfer rights.
Max India Investment Services Private Limited v.Union Of India & Ors.
The Delhi High Court stayed an order from the Ministry of Corporate Affairs that had directed petitioner, Max India Investment Services Private Limited, to change its name. The dispute arose because a respondent company claimed the petitioner's name was too similar to their registered trademarks ('MAX' and 'Max India Limited'). The court found that since the petitioner has been using the name incorporating 'Max India' since 2007, it established a prima facie case for interim relief. Furthermore, the parties were referred to mediation to explore an amicable resolution.
Hero Investcorp Private Limited Anr. v.Venuse Automobile
Hero Investcorp Private Limited filed a suit against Venuse Automobile alleging trademark infringement and passing off related to the 'HERO' brand. The Delhi High Court granted several interim reliefs in favor of the Plaintiffs, including an ex parte ad-interim injunction. Furthermore, the court appointed a Local Commissioner with powers to inspect the Defendant's premises, seize infringing auto parts bearing the HERO marks, and ascertain the stock value, signaling strong initial support for the Plaintiff's claims.
Rajput Jewellers Pvt Ltd v.Union Of India
The Delhi High Court addressed a petition filed by Rajput Jewellers Pvt Ltd challenging an ongoing complaint lodged against it by a third party regarding trademark ownership. The petitioner sought interim relief to prevent adverse orders from the Regional Director, Northern Division. While dismissing the apprehension of arbitrary action, the court issued a crucial direction, mandating that the Regional Director must dispose of the Section 16(1)(b) complaint after thoroughly considering all submissions and granting a proper hearing to all concerned parties.
Prabin Kumar Shah v.Manoj Kumar Jagnani And Ors
The Calcutta High Court heard an application for rectification filed by Prabin Kumar Shah seeking cancellation of Trademark No. 1553036 in Class 30. The court noted that the respondent's mark appeared to be slavishly imitating the petitioner's mark. Given the respondent's proposal to change the impugned mark (in color and font), the Court granted them an opportunity to revise it, while also directing them to adhere to a prior binding decree from the District Court at Bokaro.
Koninklijke Philips N.V. v.M/S Electrical Master
Philips filed a suit against Electrical Master for infringing its registered trademarks (PHILIPS), copyrights, and design rights concerning its Advanced Beard Trimmer Series 3000. The court found in favor of Philips, granting permanent injunctions, damages, and costs.
Super Milk Products Private Limited v.Pyare Lal Laxmi Narayan And Sons
The Plaintiff sued the Defendant for trademark infringement after the Franchise Agreement terminated. The Plaintiff alleged that the Defendant was clandestinely using a deceptively similar brand name, 'Cuppa Kevanter', which led to passing off of the Plaintiff's well-known trademark 'Keventers'.
Italfarmaco Spa v.Deputy Controller of Patents & designs
Italfarmaco Spa filed an appeal challenging a previous order by the Deputy Controller of Patents & Designs rejecting the grant of patent for Application No.10810/CHENP/2012. The High Court examined whether the Original Side Appeal was maintainable under Clause 15 of Letters Patent, considering the provisions of the Commercial Courts Act.
Italfarmaco Spa v.Deputy Controller of Patents & Designs
Italfarmaco Spa filed an appeal challenging the order passed by the Single Judge of the High Court of Madras. The core issue was whether this Original Side Appeal (OSA) was maintainable under Clause 15 of the Letters Patent, given that the original matter involved a rejection of patent grant under Section 15 of the Patents Act, 1970. The court held that since an appeal mechanism already existed under Section 117A of the Patents Act, the intra-Court Appeal under Clause 15 was not maintainable.
Trutzchler Gmbh And Co Kg Limited v.The Controller General Of Patents
The appellant challenged the rejection of their patent application (No. 1250/KOL/2009) based on alleged lack of inventive steps. The appeal argued that the Controller reintroduced this objection suo moto, violating natural justice principles and contradicting earlier notices where the objection had been waived.
Cardo Systems, Ltd. v.Shenzhen Asmax Infinite Technology Co., Ltd. and Hong Kong Yiheng International Technology Co., Limited
Cardo Systems, Ltd. filed an infringement action on December 16, 2024 against two defendants concerning European Patent EP 4 240 194, alleging that products Z1-ASMAX and F1-ASMAX (and their Plus, Pro, and Pro Max variants) infringed the patent. While service was successfully completed against the Hong Kong defendant on May 29, 2025, service against the Shenzhen defendant failed twice because the Chinese central authority rejected the documents due to the naming convention used for Hong Kong. The Milan Local Division addressed whether Article 15(2) of the Hague Service Convention applies in the UPC system, concluding that it is entirely applicable regardless of any additional requirements for service within each Member State.
Sanofi SA as successor of Sanofi Mature IP a.o. v.Reddy Pharma SAS a.o.
This case concerned European Patent 2,493,466, held by Sanofi SA, relating to a novel anti-tumoral use of cabazitaxel for treating prostate cancer. Sanofi filed infringement actions against STADA, Dr. Reddy, and Zentiva entities for marketing generic versions of its JEVTANA product, while the defendants filed counterclaims for revocation. The Local Division Munich revoked the patent in its entirety for lack of inventive step, dismissed the infringement actions, and ordered Sanofi to bear the costs.
ASUS Technology Licensing Inc. v.Guangdong OPPO Mobile Telecommunications Corp. Ltd a.o.
The defendants applied under Rule 158 RoP for an order requiring the claimant, ASUS Technology Licensing Inc. (established in Taiwan), to provide security for costs of the proceedings concerning European patent EP 3 346 616. The Local Division Munich held that enforcing a cost decision in Taiwan would be at least unduly burdensome, as neither Taiwanese legislation nor any international agreement provides certainty for such enforcement. The court ordered the claimant to provide security of EUR 200,000 within six weeks, but rejected the request for security concerning a counterclaim for revocation that had not yet been filed.
Trutzchler Gmbh And Co Kg Limited v.The Controller General Of Patents
The appellant challenged the Controller's decision to reject its patent application (1250/KOL/2009) primarily on grounds of lacking inventive steps. The appellant argued that the reintroduction of this objection after amendments and previous hearings violated natural justice principles. The High Court found that the procedure was against the scheme of the Act, setting aside the rejection order.
Novo Nordisk A/S v.Dr Reddys Laboratories Limited & Anr.
Novo Nordisk A/S appealed an order where a Single Judge found infringement and granted limited relief to Dr Reddys Laboratories Limited. The appeal centers on whether the suit patent (IN 2626971) is vulnerable to invalidity under Section 64 of the Patents Act, given that the learned judge found the claim obvious from prior art.
Italfarmaco Spa v.Deputy Controller of Patents & designs
Italfarmaco Spa filed an appeal challenging the order passed by the Single Judge of the High Court of Madras. The core issue was whether this Original Side Appeal (OSA) was maintainable under Clause 15 of the Letters Patent, given that the underlying matter involved a decision made under Section 117A of the Patents Act, 1970. The court held that since the Commercial Courts Act is a special enactment and provides specific appeal mechanisms, the intra-Court Appeal under Clause 15 was not maintainable.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.